Aspira Women's Health

Aspira Women's Health is a research company dedicated to novel high-value diagnostic products and bioanalytical solutions aimed at addressing unmet needs in gynecologic oncology and women’s health. By developing and leveraging these technologies, the company assists physicians in diagnosing, treating, and improving gynecological conditions in women, thereby helping transform women’s health. These methods enable physicians to assess health risks, optimize patient management, and improve women’s gynecological health. Our FDA-approved products, OVA1® and OVERA®, assess the risk of ovarian malignancy in women with adnexal masses. The recently launched Aspira GenetiXSM test offers targeted and comprehensive genetic testing options for gynecological conditions. With over 10 years of experience in ovarian cancer risk assessment, Aspira Women's Health possesses cutting-edge research expertise that informs our next-generation products. Our focus is on delivering products that enable healthcare providers to stratify risks, facilitate early detection, and optimize treatment plans.